Sep 30

Science Highlights

SH 05 - Genitourinary Cancer - Science Highlights

Room 109

08:00am - 08:30am ET

Genitourinary Cancer

MODERATOR(S)

Leslie Ballas, MD, FASTRO - Cedars Sinai

Stanley Liauw, MD, FASTRO - University of Chicago

Credits

AMA PRA Category 1 Credits:

0.50

Rate This Session

Presentations

08:00am - 08:05am ET

Germline Biomarker for Late Genitourinary Adverse Events after Radiotherapy for Prostate Cancer: Validation in Multiple Prospective Trials

Speaker: Amar Kishan, MD - UCLA, Culver City
08:05am - 08:10am ET

Brachytherapy Versus External Beam Dose-Escalated Boost for Intermediate-Risk Prostate Cancer: Definitive Results of the GETUG P05 Trial

Speaker: Ariane Lapierre, MD, PhD - Hospices Civils de Lyon, Pierre Benite
08:10am - 08:15am ET

Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003

Speaker: Mark Buyyounouski, MD, MS, FASTRO - Stanford University, Stanford
08:15am - 08:20am ET

Evaluation of PAM50 Molecular Subtypes in Post-Prostatectomy Salvage Radiotherapy: An NRG Oncology-RTOG 0534 Analysis<em></em>

Speaker: Shuang Zhao, MD, MSE - UT MD Anderson Cancer Center, Houston
08:20am - 08:25am ET

Discussant

Speaker: Stanley Liauw, MD, FASTRO - University of Chicago, Chicago